On Raj Shamani's podcast, Biocon Executive Chairperson Kiran Mazumdar-Shaw explained her habit of entering markets years early. "It's in my DNA. I've always wanted to lead, not follow," she said. She noted one in two statin tablets worldwide uses Biocon's API, a lead built by leaving the herd.